In summary, these results contribute to a better understanding of the tumour suppressor effects of metformin, by showing that the drug decreases the expression of several important oncoproteins, including c-MYC, VEGF and β-catenin, and likely does so via a pathway involving miR modulation. This evidence concerns the gene VEGFA and neoplasm.